Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

RMD ResMed Inc

219,97

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 13:35:47

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

ResMed (NYSE:RMD)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more ResMed Charts.

ResMed (NYSE:RMD)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more ResMed Charts.

News ResMed Inc

ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
Donnerstag 16 Mai 2024 (16 Stunden vor) • GlobeNewswire Inc.

MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data Access
Donnerstag 16 Mai 2024 (1 Tag vor) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Mittwoch 15 Mai 2024 (2 Tage vor) • Edgar (US Regulatory)

ResMed Announces Participation in the RBCCM Global Healthcare Conference
Dienstag 7 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
Donnerstag 25 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
Donnerstag 4 April 2024 (1 Monat vor) • GlobeNewswire Inc.

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
Freitag 15 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
Mittwoch 6 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 1 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere ResMed Inc News-Artikel

First Rep Corp America (CE)

Vontobel Financial Produ...

Starstream Entertainment (PK)

Hardy Underwriting

PETRR227 Ex:19,95

Crown Electrokinetics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen